Latest Updates

HFC/HFSA Research Award Nominations
Please submit your nominations for this year’s awards to be presented at the HFSA Annual Scientific Meeting 2021, taking place Sept. 10-13, 2021.

HFC/HFSA Research Award Nominations

HFC Lean CRF

HFC Lean CRF: Expanded Laboratory Details
Click to download

HFC Lean CRF: Expanded Laboratory Details

HFC Lean CRF: Durable MCS Module
Click to download

HFC Lean CRF: Durable MCS Module

HFC Lean CRF: Electrocardiogram Details Module
Click to download

HFC Lean CRF: Electrocardiogram Details Module

HFC Lean Case Report Form
Click to download

HFC Lean Case Report Form

COVID-19 Resources

COVID CRF
Click to download various documents.
HFC Letter - Impact of COVID-19
The mission of the HFC has focused largely on clinical trials, and the impact of COVID-19 on clinical research will be significant.

HFC Letter - Impact of COVID-19

Dear Friends and Colleagues,

The mission of the HFC has focused largely on clinical trials, and the impact of COVID-19 on clinical research will be significant. The FDA has issued the following guidance with suggestions and recommendations. We have offered to collect any questions not addressed in the guidance and pass them along on behalf of HFC members. We hope this will be helpful in answering the many questions we are all facing.

https://www.fda.gov/regulatory-information/search-fda-guidance-documents/fda-guidance-conduct-clinical-trials-medical-products-during-covid-19-pandemic

Kind regards,

Mona Fiuzat, Chris O’Connor, JoAnn Lindenfeld, Bill Abraham, Mitch Psotka, Bram Zuckerman, Norman Stockbridge
Heart Failure Collaboratory Co-Chairs and Members

Learning Amidst a Pandemic: Collecting COVID-19 Data Across Cardiovascular Clinical
Click to read a blog by Ankeet Bhatt, MD, MBA posted on CVCTCardioBrief.

Learning Amidst a Pandemic: Collecting COVID-19 Data Across Cardiovascular Clinical

COVID-19 Information: FDA guidance on statistical considerations for clinical trials during the pandemic
“Statistical Considerations for Clinical Trials During the COVID-19 Public Health Emergency Guidance for Industry”

COVID-19 Information: FDA guidance on statistical considerations for clinical trials during the pandemic

NIH Guidance for NIH-funded Clinical Trials and Human Subjects Studies Affected by COVID-19
The purpose of this notice is to provide guidance outlining the flexibilities available to recipients conducting NIH-funded clinical trials and human subject studies, that are impacted by the declared public health emergency for COVID-19.

NIH Guidance for NIH-funded Clinical Trials and Human Subjects Studies Affected by COVID-19

HFC/HFSA Research Network Awards

HFC-HFSA 2020 Research Network Awards
The Heart Failure Collaboratory is proud to announce the winners of the 2020 HFC – HFSA Research Network Awards.

HFC-HFSA 2020 Research Network Awards

The Heart Failure Collaboratory is proud to announce the winners of the 2020 HFC – HFSA Research Network Awards. This joint effort recognized individuals and sites in the following categories: Research Site, Principal Investigator and Site Coordinator. Below is a list of all awardees:

Principal Investigator Awardees

PI Research Site Trial (s)
Amin Yehya, MD Sentara Healthcare VICTORIA
Andrew Sauer, MD University of Kansas Medical Center GALACTIC-HF
Scott Feitell, DO Rochester General Hospital RELIEVE-HF
Rhondalyn McLean, MD, MHS University of Pennsylvania GENETIC-HF

Zepatier For Treatment Of Hepatitis C-Negative Patients Who Receive Heart Transplants From Hepatitis C-Positive Donors (HCV)

Freny Mody, MD V.A. Greater Los Angeles Healthcare System TRANSFORM-HF
Sandhya Murthy, MD Montefiore Medical Center – Albert Einstein College of Medicine TRANSFORM-HF
Gerin Stevens, MD Northwell Health – Manhasset TRANSFORM-HF
Sara Saberi, MD Michigan Medicine Cardiology Clinic EXPLORER-HCM, MAVA-LTE

Site Coordinator Awardees

Name Research Site Trial (s)
Alyssa Boyce-White University of Kansas Medical Center GALACTIC-HF
Connie Watson University of Mississippi EMPERIAL- reduced and preserved
ANTHEM-HF
VITALITY HFpEF
PIONEER-HF
PANTHEON
VICTORIA
PARAGON-HF
SOCRATES- reduced and preserved
INTERVENE-HF
Dilated CMP Precision Medicine Study
COUNTER HF
Patricia Noll Rochester General Hospital RELIEVE-HF
Mary Sheehan Brigham and Women’s Hospital EXPLORER-HCM, MAVA-LTE, MAVERICK, MYK-491-006

 

Research Site Awardees

Research Site PI/

Site Coordinator (s)

Trial
Sentara Norfolk General Hospital John Herre, MD/

Brittany McMichael

TRANSFORM-HF
V.A. Medical Center/University of Maryland Stephen Gottlieb, MD/

Mary Bowers-Lash

TRANSFORM-HF
Henry Ford Health System Gillian Grafton, MD/

Kelsey Neaton

TRANSFORM-HF
Oregon Health & Science University (OHSU) Johannes Steiner, MD/

John Halvorson

CY 1031 // METEORIC-HF – NCT03759392
Jacksonville Center for Clinical Research of the Encore Research Group Micheal Koren, MD/

Richard W Smith, RN

MYK491-003
Glacier View Research Institute, Cardiology Eve Gillespie, MD, PHD/

Lucia Kufa

Brandy Anderson

Chelsey Stocker

METEORIC-HF
University of Pennsylvania Tiffany Sharkoski, MPH, MBE, CCRC (HF Program Mgr.) eMAP

eCool-AF

HFC-HFSA 2019 Research Network Awards
The Heart Failure Collaboratory is proud to announce the winners of the HFC – HFSA Research Network Awards.

HFC-HFSA 2019 Research Network Awards

The Heart Failure Collaboratory is proud to announce the winners of the HFC – HFSA Research Network Awards. In its inaugural year, this joint effort recognized individuals and sites in the following categories: Research Site, Principal Investigator and Site Coordinator. Below is a list of all awardees:

 


Pictured left to right:
Stephen Heitner, MD, Mitchell Psotka, MD, PhD, Chris O’Connor, MD, HFSA President 2017-2018, Randy Starling, MD, HFSA President 2018-2019, Biykem Bozkurt, MD, HFSA President 2019-2020, Palak Shah, MD

 

 

Pictured left to right:
Biykem Bozkurt, MD, HFSA President 2019-2020, Randy Starling, MD, HFSA President 2018-2019, Palak Shah, MD, Mitchell Psotka, MD, PhD, Venkatesh Nadar, MD, Anjali Owens, MD, Chris O’Connor, MD, HFSA President 2017-2018

 

 

Pictured left to right:
Biykem Bozkurt, MD, HFSA President 2019-2020, Randy Starling, MD, HFSA President 2018-2019, Amanda Radle, MS, Lydia McGowan, MS, CCRP, Chris O’Connor, MD, HFSA President 2017-2018

Meeting Brochures

2021 March 12th Meeting - Agenda
Optimal Background Medical Therapy for Clinical Trials.

2021 March 12th Meeting - Agenda

HFC Relevance of Non Primary Endpoints
March 2019 - Agenda Participants List

HFC Relevance of Non Primary Endpoints

Interpreting and Implementing New Clinical Trials Data
March 2020 - Agenda Participants List

Interpreting and Implementing New Clinical Trials Data

Optimal Background Medical Therapy for Clinical Trials
March 2021 - Agenda Participants List

Optimal Background Medical Therapy for Clinical Trials